Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00818493 · ClinicalTrials.gov registry record · Phase 2
Pilot Study of the Efficacy and Safety of Q8003 in Patients Who Have Undergone Total Knee Arthroplasty or Total Hip Arthroplasty
A Phase 2 study, sponsored by QRxPharma.
- Completed
- Registry status
- Phase 2
- Development phase
- 44
- Enrollment target
NCT00818493 is a Phase 2 study that has completed, run by QRxPharma. The registered enrollment target is 44 participants.
The verdict
NCT00818493, a Phase 2 study, has completed, sponsored by QRxPharma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 44 participants
- Enrollment target
Study Summary
This is a Phase 2 3-arm, open label pilot study of the safety and efficacy of Q8003 in patients who have undergone primary unilateral total knee arthroplasty or total hip arthroplasty.
Interventions
- DRUG Q8003 (morphine sulfate and oxycodone hydrochloride)
- DRUG Low dose Q8003 (morphine sulfate and oxycodone hydrochloride)
- DRUG Percocet (oxycodone and acetaminophen)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00818493
The ClinicalTrials.gov registry entry for NCT00818493 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is QRxPharma, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Q8003 (morphine sulfate and oxycodone hydrochloride) is the first listed.
NCT00818493 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00818493 about?
NCT00818493 is a clinical study titled "Pilot Study of the Efficacy and Safety of Q8003 in Patients Who Have Undergone Total Knee Arthroplasty or Total Hip Arthroplasty". This is a Phase 2 3-arm, open label pilot study of the safety and efficacy of Q8003 in patients who have undergone primary unilateral total knee arthroplasty or total hip arthroplasty.
What is the current status of trial NCT00818493?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 44 participants. The study started on 2009-02. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00818493?
The interventions under investigation include: Q8003 (morphine sulfate and oxycodone hydrochloride) (DRUG), Low dose Q8003 (morphine sulfate and oxycodone hydrochloride) (DRUG), Percocet (oxycodone and acetaminophen) (DRUG).
Who is sponsoring clinical trial NCT00818493?
This trial is sponsored by QRxPharma, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.